50
Participants
Start Date
April 23, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2026
Trifluridine/tipiracil
patients received biweekly Trifluridine/tipiracil (30 mg/m2 twice daily; days 1-5), irinotecan (150 mg/m2; day 1) and bevacizumab (5 mg/kg; day 1).
RECRUITING
Qilu hospital of Shandong University, Jinan
The Affiliated Hospital of Qingdao University
OTHER
Shandong Provincial Hospital
OTHER_GOV
Qianfoshan Hospital
OTHER
Binzhou People's Hospital
OTHER
Binzhou Medical University
OTHER
Yantai Yuhuangding Hospital
OTHER
Linyi Tumour Hospital
OTHER
Qilu Hospital of Shandong University
OTHER